Recent Updates
Recently added Catalysts

Commercial acetaminophen

Phase 3

Post-operative Dental Pain | Small molecule | Pain |Johnson & Johnson|Last Updated: Apr 15, 2021

Success Probability
Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
Premium
Market & Valuation
rNPV $3.2B
Market Size $9.4B
Revenue Basis $1.6B
Competitors 6
Premium
Trial Design
RandomizedDouble-BlindPLACEBO_CONTROLLEDBiomarker
Total Trials1
Total Enrollment664
FDA Designations
No designations recorded
Clinical Trials (1)
NCT IDTitlePhaseStatusEnrollmentVelocityDesignStartCompletionLast UpdatedSitesCountries
NCT03224403Randomized, Double-Blind, Single-Dose, Efficacy and Safety Study of Test Acetaminophen Tablet in Postoperative Dental PainPHASE3 COMPLETED 664Jul 19, 2017Apr 12, 2018Apr 15, 20211 United States
Unlock Drug Trial Details
Study Endpoints
Primary Endpoints
Time to Confirmed Perceptible Pain Relief
within 4 hours

Minutes until confirmed perceptible pain relief is achieved. Stopwatch is started after the participant takes the study medication. The participant is instructed to stop the stopwatch when they first begin to feel any pain relief. The perceptible pain relief is confirmed if the participant also stopped the second stopwatch indicating meaningful pain relief.

Secondary Endpoints
Time to Meaningful Pain Relief
Within 4 hours
Percentage of Participants With Confirmed Perceptible Relief From 30 Minutes to Successively Earlier Minutes in One-minute Increments - 30 Minutes
by 30 minutes
Percentage of Participants With Confirmed Perceptible Relief From 30 Minutes to Successively Earlier Minutes in One-minute Increments - 29 Minutes
by 29 minutes
Unlock Study Endpoints
Study Design & Arms
AllocationRANDOMIZED
MaskingQUADRUPLE
ModelPARALLEL
PurposeTREATMENT
Treatment Arms
ArmTypeDescription
Test acetaminophenEXPERIMENTALTest acetaminophen 1000 mg dose
Commercial acetaminophenACTIVE_COMPARATORCommercial acetaminophen 1000 mg dose
Commercial ibuprofenACTIVE_COMPARATORCommercial ibuprofen, 400 mg dose
PlaceboPLACEBO_COMPARATORPlacebo
Interventions
NameTypeDescription
Test acetaminophenDRUGsingle dose of 2 Test acetaminophen 500 mg tablets
Commercial acetaminophenDRUGsingle dose of 2 acetaminophen 500 mg caplets
Commercial ibuprofenDRUGSingle dose of 2 ibuprofen 200 mg Liquid-filled Capsules
PlaceboDRUG2 placebo caplets
Unlock Study Design Details
Eligibility Criteria
Age Range17 Years — 50 Years
SexALL
Healthy VolunteersNo
Study Sites1

Inclusion Criteria: 1. 17 to 50 years old 2. Weigh 100 lbs. or greater and have a body mass index (BMI) of 18 to 30 (inclusive) 3. Dental extraction of three or four third molars 4. Meets post-surgical pain criteria 5. Females of childbearing age must be willing to use acceptable method of birth co...

Countries:United States
Unlock Eligibility Criteria